
|Articles|July 1, 2000
The American Journal of Managed Care
- July 2000
- Volume 6
- Issue 7
Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity
Advertisement
Articles in this issue
over 25 years ago
Improving the Sensitivity of Cervical Cytology: What Are the Issues?over 25 years ago
Why Are Drug Prices Lower in Canada?over 25 years ago
Design and Implementation of an Inpatient Disease Management ProgramNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants
3
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
4
Pembrolizumab Achieved pCR in Patient With Recurrent DDLPS
5










































